To evaluate to effect of experimental dry eye on ocular surface apoptosis. METHODS. Aqueous tear production and clearance were inhibited by systemic administration of scopolamine and exposure to an air draft for 12 days in 4-to 6-week-old 129SvEv/CD-1 mixed white mice. Eyes and ocular adnexa were excised, cryosectioned, and evaluated for apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick end labeling (TUNEL) assay, immunohistochemical assay for caspase-3 and poly(ADP-ribose) phosphate (PARP), and examination of nuclear morphologic changes by Hoechst DNA nuclear staining and transmission electron microscopy. RESULTS. The number of TUNEL-positive cells in the mice with induced dry eye was significantly increased compared with control mice in the following ocular regions: central corneal (P Ͻ 0.0014), peripheral corneal (P Ͻ 0.0001), bulbar conjunctival (P Ͻ 0.0021), and tarsal conjunctival (P Ͻ 0.0046) epithelia; tarsal conjunctival stroma (P Ͻ 0.0274); and lid margin (P Ͻ 0.0219, n ϭ 4 in all cases). There were no significant differences observed between treated and control groups in the central corneal, peripheral corneal, or bulbar conjunctival stroma; meibomian glands; skin; retina-choroid; or episcleral regions. Immunohistochemistry for caspase-3 and poly(ADPribose) polymerase p85 fragment revealed increased immunoreactivity in regions of increased TUNEL positivity, particularly in the corneal and conjunctival epithelial cells. Ultrastructural morphologic changes consistent with apoptosis were observed in the conjunctival epithelial cells. CONCLUSIONS. Experimentally induced dry eye in mice causes apoptosis of cells in ocular surface tissues including the central and peripheral corneal epithelium, bulbar and tarsal conjunctival epithelia, tarsal conjunctival stroma, and lid margin. Apoptosis may play a key role in the pathogenesis of keratoconjunctivitis sicca and may be a therapeutic target for this condition. (Invest Ophthalmol Vis Sci.
D
ysfunction of the integrated ocular surface-lacrimal gland functional unit causes the ocular surface disease keratoconjunctivitis sicca (KCS). 1 The ocular surface in this condition is poorly lubricated because of decreased production of mucins by the stratified epithelia and conjunctival goblet cells and has altered barrier function manifesting clinically as increased permeability to fluorescein dye. 2 Instability of the precorneal tear film and punctate epitheliopathy cause blurred and fluctuating vision. The cause of these pathologic changes is currently unknown; however, there is mounting evidence that inflammation may play an important role.
Evidence for immune-based inflammation in dry eye includes increased density of inflammatory cells and elevated levels of inflammatory cytokines [3] [4] [5] and proapoptotic factors 6 -9 in the ocular surface and tear film. The relationship between ocular surface inflammation and apoptosis has also been the subject of much investigation. Expression of proapoptotic markers (Fas, Fas ligand, APO2.7, CD40, and CD40 ligand) by the conjunctival epithelium in KCS has been found to be significantly higher than in normal eyes and is positively correlated with expression of HLA-DR class II antigen, an immune activation marker. 6, 7 After 6 months of therapy with cyclosporin A , the levels of cell membrane markers for apoptosis (i.e., Fas) and inflammation, such as HLA-DR, were significantly reduced. 8 In studies of chronic idiopathic canine KCS, increased apoptosis was observed in epithelial cells and decreased apoptosis in lymphocytes in the conjunctiva and lacrimal glands. 9 Immunohistochemistry studies demonstrated that p53, Fas, and Fas ligand were elevated in lacrimal acinar cells and conjunctival epithelial cells in dogs with dry eye. 9 In contrast, low levels of expression of Bcl-2, an antiapoptosis marker, was observed in these tissues. After treatment with topical cyclosporin A, induction of apoptosis in lymphocytes and suppression of apoptosis in conjunctival epithelial cells was observed in these animals. 9 In lacrimal acinar cells, a decrease in p53 and an increase in Bcl-2 was also observed after treatment with cyclosporin A. 9 Although apoptosis has been demonstrated in chronic dry eye in humans and dogs, no studies have been undertaken to evaluate the occurrence and kinetics of apoptosis on the ocular surface after acute induction of dry eye. We investigated whether apoptosis develops on the ocular surface after experimental induction of dry eye in a mouse model of KCS, using three different techniques: the TUNEL assay, which detects DNA fragmentation; immunodetection of two cellular markers of apoptosis: activated caspase-3 (a downstream effector protease) and cleaved poly(ADP-ribose) polymerase (PARP; a nuclear DNA-binding protein); and examination of cell nuclei for morphologic changes characteristic of apoptosis by nuclear staining with a DNA-binding dye, and transmission electron microscopy.
MATERIALS AND METHODS

Animal Treatment and Tissue Collection
All animal research protocols were approved by the Baylor College of Medicine Center for Comparative Medicine and conformed to the standards in the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Aqueous tear production and clearance were inhibited by subcutaneous injection of scopolamine (1 mg in 0.2 mL) three times daily in the flanks of 4-to 6-week-old 129SvEv/CD-1 white mice. Dry eye was induced in mice with a modification of a previously described technique. 10 Mice were exposed to a continuous air draft from a fan placed 6 in. in front of the cage in an environmentally controlled room (50% humidity, 18°C) for 10 hours a day for 12 consecutive days. These treatments cause a statistically significant decrease in aqueous tear production and tear clearance that results in increased corneal epithelial permeability to fluorescein dye, conjunctival squamous metaplasia, and loss of goblet cells. 10 Mice were killed and their eyes and adnexa were excised, embedded in optimal cutting temperature (OCT) compound (VWR, Swannee, GA), flash frozen in liquid nitrogen, and sectioned with a cryostat (HM 500; Micron, Waldorf, Germany) into 5-m sagittal slices that were placed on microscope slides (Superfrost/Plus; Fisher, Houston, TX). These were stored at Ϫ80°C until they were used in the studies of apoptosis.
Apoptosis Evaluation
A combination of immunohistochemical and morphologic studies were used to study apoptosis in our mouse model. Specifically, assays for DNA fragmentation (TUNEL), caspase 3 activation, and PARP cleavage were performed for immunohistochemical characterization of apoptosis; transmission electron microscopy and Hoechst dye nuclear staining were used for morphologic characterization of nuclear changes observed in apoptosis.
The terminal deoxynucleotidyl transferase-mediated dUTP-nick end labeling (TUNEL) assay, which detects 3Ј hydroxyl ends in fragmented DNA as an early event in the apoptotic cascade, 11 was performed with a kit (ApopTag; Intergen Co., Purchase, NY), using a modification of the manufacturer's protocol as previously described. 11, 12 Cryosections of whole mouse eyes were fixed in 1% paraformaldehyde, and cell membranes were permeabilized with 2:1 ethanol:acetic acid solution. The samples were incubated with TdT enzyme and 11-digoxigenin dUTP at 37°C for 90 minutes. After quenching the reaction, samples were blocked with blocking solution and incubated with anti-digoxigenin FITC-conjugated antibody for 60 minutes at room temperature. One cryosection was incubated with 1 g/mL DNase I in TdT buffer for 30 minutes at room temperature before incubation with TdT enzyme and 11-digoxigenin dUTP as a positive reaction control.
After completion of the initial TUNEL procedure, the cryosections were evaluated for expression of activated caspase-3. After three washes in phosphate-buffered saline (PBS, pH 7.2), tissue samples were incubated with 5 g/mL polyclonal rabbit anti-active caspase-3 primary antibody (PharMingen, San Diego, CA) or PBS as a primary antibody negative control at 4°C overnight. Samples were then blocked with 10% goat serum for 30 minutes at room temperature and incubated with goat anti-rabbit conjugated antibody (Alexa Fluor 594; Molecular Probes, Eugene, OR) for 45 minutes at room temperature, followed by three washes in PBS. Nuclei were then counterstained using 0.5 g/mL Hoechst 33342 dye (Sigma, St. Louis, MO) in approximately 30 L mounting gel (Gel Mount; Fisher) and a 22 ϫ 50-mm coverslip (Fisher) then applied.
Apoptotic cells in different regions of the ocular surface were assessed by epifluorescence microscope (Eclipse E400; Nikon, Garden City, NY) . Photographs at 400ϫ magnification were taken of representative areas of the cornea, bulbar conjunctiva, and tarsal conjunctiva. All TUNEL-positive cells were counted in the conjunctiva in 100-m length ϫ 100-m width areas in the sagittal sections and in the cornea in 100-m length ϫ 20-m width areas in the sagittal sections. A Student's t-test was used to analyze statistical significance of the data collected.
Immunodetection of the PARP p85 fragment was performed by immunofluorescent staining of cryosections that were fixed in 100% methanol at 4°C for 10 minutes. After three washes in PBS, samples were blocked with 10% goat serum for 30 minutes at room temperature and incubated for 2 hours at room temperature with a 1:50 dilution of rabbit anti-mouse PARP p85 fragment antibody (Promega, Madison, WI) or PBS, as a primary antibody negative control. After three washes in PBS, samples were incubated with goat anti-rabbit conjugated antibody (Alexa Fluor 488; Molecular Probes) for 45 minutes at room temperature, followed by three washes in PBS and nuclei counterstaining with 0.5 g/mL Hoechst 33342 dye (Sigma).
For transmission electron microscopy, the cornea and conjunctiva were excised from treated and control mice. The tissues were diced carefully into 1-mm cubes, to avoid crushing, and fixed in 3% glutaraldehyde buffered to pH 7.2 with 0.01 M piperazine-N,NЈ-bis(2-ethane sulfonic acid [PIPES]) for 1 hour. They were rinsed in buffer and postfixed in PIPES-buffered osmium tetroxide (pH 7.2) for 1 hour at room temperature, rinsed in several changes of distilled water, and dehydrated through a graded series of ethanol. The dehydrated tissues were incubated in two 45-minute changes of propylene oxide followed by a 1:1 mixture of propylene oxide and Spurr resin for 1.5 hours. The tissue pieces were then incubated in pure resin for 1.5 hours, after 
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which they were transferred to fresh resin in block molds and allowed to cure at 60°C overnight. Sections cut 1 m thick from the hardened blocks were mounted on glass slides, stained with an alcoholic solution of toluidine blue and basic fuchsin and examined by light microscope. Areas of interest were trimmed, and 60-nm sections were cut and mounted on copper grids (300 mesh). The grids were stained with uranyl acetate and lead citrate and photographed with an electron microscope (model 100C Temscan; JEOL, Peabody, MA; and 4489 film; Eastman Kodak, Rochester, NY).
RESULTS
As previously reported, mice treated with systemic scopolamine injections and subjected to an air draft and desiccating environment showed a significant decrease in aqueous tear production and clearance by day 4 that was sustained throughout the treatment period. 10 Dryness was accompanied by development of KCS, with loss of conjunctival goblet cells and increased corneal epithelial permeability to carboxyfluorescein. 10 Apoptosis in the cornea and conjunctiva was assessed in mice treated in this fashion for 12 days and in untreated control animals. 
TUNEL and Caspase-3 Immunostaining
Normal, untreated control mice exhibited minimal apoptosis assessed by TUNEL staining in the cornea and conjunctiva (Table 1, Fig. 1 ). The number of TUNEL-positive cells was significantly increased in mice with induced dry eye compared with control mice in the following ocular surface tissues: central and peripheral corneal and bulbar and tarsal conjunctival epithelia; tarsal conjunctival stroma; and lid margin ( Table 1 , Fig. 1 ). There were no significant differences between dry eye and control groups in the central corneal, peripheral corneal, or bulbar conjunctival stroma; meibomian glands; skin; retinachoroid; or episcleral regions (Table 1) .
Positive control experiments revealed TUNEL-positive cells throughout all regions of the eye including the cornea, bulbar and tarsal conjunctiva, retina, and choroid (Fig. 2) .
Immunofluorescent staining for active caspase 3 revealed increased immunoreactivity in regions of TUNEL positivity. Specifically, active caspase 3 activity was localized to the central corneal epithelium, peripheral corneal epithelium, superficial conjunctival epithelium, and lid margins of the mouse with induced dry eye. This staining was not observed in the negative control for which secondary antibody alone was used (data not shown).
Anti-PARP p85 Fragment Immunostaining
PARP p85 fragment staining revealed positive cells in the central and peripheral corneal and the bulbar and tarsal conjunctival epithelia and stroma in the treated mice. The punctate and diffuse pattern of PARP staining was similar to that observed in apoptotic liver epithelial cells. 13 The cells showing the strongest staining for PARP in the tarsal conjunctival and central corneal epithelia of treated mice (Fig. 3) . In contrast, only nonspecific staining of the conjunctival epithelial basement membrane and weak diffuse cytoplasmic staining was noted in untreated control mice (Fig. 3) . No staining was observed in the secondary antibody alone control (data not shown).
Hoechst 33342 Nuclear Staining
Nuclear staining of the cornea and conjunctiva with Hoechst 33342 revealed dysmorphic nuclear architecture and fragmented nuclear material in the treated mice compared with control animals (Fig. 4) .
Transmission Electron Microscopy
Ultrastructural nuclear changes consistent with apoptosis were observed in the cornea and conjunctiva of treated mice. Nuclear chromatin condensation and peripheral migration of chromatin, as shown in a representative section in Figure 5 , were noted in many conjunctival epithelial cells. These nuclear changes were rarely observed in the conjunctival stromal cells.
Fewer apoptotic cells were noted in the corneal epithelium than in the conjunctiva. Although some nuclear condensation and peripheral margination of chromatin were observed in occasional corneal epithelial cells, nuclear fragmentation to the extent of that in the conjunctival epithelium was not observed.
DISCUSSION
Although apoptosis of ocular surface cells has been detected in chronic dry eye in dogs and humans, our experiments indicate that apoptosis is an acutely inducible event that accompanies the development of KCS in our experimental mouse model of dry eye. Apoptosis on the ocular surface was demonstrated by several markers and by characteristic nuclear morphologic changes. The TUNEL assay revealed DNA fragmentation suggestive of apoptosis in multiple ocular surface tissues, including the central and peripheral corneal epithelium, bulbar and tarsal conjunctival epithelia, tarsal conjunctival stroma, and lid margin in mice with induced dry eye. Immunohistochemistry for caspase 3 and PARP and ultrastructural studies using transmission electron microscopy suggest that the most marked apoptosis occurred in the superficial bulbar conjunctival epithelium. Although TUNEL staining was observed in the peripheral and central corneal epithelium, less ultrastructural evidence of apoptosis was observed at these sites than in the conjunctival epithelial tissues. It is possible that the TUNEL assay may detect cells entering the apoptotic pathway before dissolving into irreversible nuclear fragmentation or it may detect other nonspecific DNA changes induced by ocular surface dryness.
Apoptosis occurs through two pathways, an extrinsic pathway involving the interaction of death ligands (e.g., TNF-␣, Fas ligand) with their respective cell surface receptors and an intrinsic pathway that is initiated by insults that damage the DNA, such as ultraviolet light and chemotherapeutic agents. Both pathways eventually result in mitochondrial damage with release of cytochrome c and downstream activation of caspases, such as caspase 3. Activation of other downstream caspases results in cleavage of cellular proteins, such as PARP, cytokeratin 18, and other caspases, that lead to the morphologic and biochemical changes of apoptosis (Fig. 6 ). 14, 15 Poly(ADP-ribose) polymerase (PARP) is a nuclear DNA-binding protein that functions in DNA base excision repair. 16 PARP cleavage results in a decreased enzymatic repair function and contributes to the progression of apoptosis, although PARP Detection of the activated caspase 3 and PARP p85 fragment in the bulbar and tarsal conjunctival epithelium and in the central and peripheral corneal epithelium of the treated mice in our study suggests that these apoptotic mediators may be involved in the pathogenesis of dry eye. Although the precise pathway by which apoptosis occurs in dry eye has not yet been elucidated, we believe that this phenomenon may play a crucial role in its pathogenesis and in the clinical manifestations of KCS. The proinflammatory ocular surface milieu that develops in dry eye could certainly activate extrinsic pathways of apoptosis. For example, increased expression of the proapoptotic cytokines, TNF-␣ and IL-1, have been detected in the conjunctival epithelium and tear fluid of patients with KCS. 19, 20 Whether the occurrence of apoptosis is a physiologic response to an ocular surface insult or a critical element in the pathogenesis of the ocular surface disease in dry eye may be delineated by further natural history studies correlating apoptosis with clinical progression of dry eye. However, the death of cells responsible for ocular surface health and protection, such as the conjunctival goblet cells, could contribute to progression of KCS. Furthermore, the punctate epithelial erosions that are observed in the cornea and conjunctiva of patients with KCS could be attributed to sloughing of apoptotic epithelial cells.
Our studies suggest that apoptosis may play a key role in the pathogenesis of KCS. Characterization of apoptotic pathways may provide therapeutic targets for the treatment of KCS. As previously reported, one of the therapeutic mechanisms of cyclosporin A in dry eye could be inhibition of mitochondrial pathways of apoptosis. 9 Cyclosporin A has been reported to prevent the mitochondrial permeability transition that proceeds apoptotic cell death. 21, 22 
